Nathan B. Fountain's Insider Trades & SAST Disclosures

Nathan B. Fountain's most recent trade in Acumen Pharmaceuticals Inc was a trade of 19,500 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 4, 2025.

Share

Note

This is a custom search result for pattern Nathan B. Fountain.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.

All Superstars

"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches "Balanced Fund" but not "Balanced Growth Fund" Balanced Fund: Use this format without quotation marks to search for all funds related to the term "Balanced Fund" The results may include "Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".

Stock	Client Name	Client Category	Action	Reported to Exchange	Quantity	Post Transaction Holding	Traded %	Avg. Price	Value	Security Type
Acumen Pharmaceuticals Inc	Nathan B. Fountain	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Jun 2025	19,500	19,500	-		-	Stock Option (right to buy)
Acumen Pharmaceuticals Inc	Nathan B. Fountain	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	04 Jun 2025	12,800	19,050	-		0	Common Stock
Acumen Pharmaceuticals Inc	Nathan B. Fountain	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	10 Jun 2024	25,000	25,000	-		-	Stock Option (right to buy)
Acumen Pharmaceuticals Inc	Nathan B. Fountain	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	06 Jun 2023	25,000	25,000	-		-	Stock Option (right to buy)
Acumen Pharmaceuticals Inc	Nathan B. Fountain	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	15 Jun 2022	25,000	25,000	-		-	Stock Option (right to buy)
Acumen Pharmaceuticals Inc	Nathan B. Fountain	Director	Purchase of securities on an exchange or from another person at price $ 16.00 per share.	06 Jul 2021	6,250	6,250	-	16	100,000	Common Stock
Acumen Pharmaceuticals Inc	Nathan B. Fountain	Director	Purchase of securities on an exchange or from another person at price $ 16.00 per share.	06 Jul 2021	6,250	6,250	-	16	100,000	Common Stock
Acumen Pharmaceuticals Inc	Nathan B. Fountain	Director	Grant, award, or other acquisition of securities at price $ 0.00 per share.	30 Jun 2021	34,000	34,000	-		-	Stock Option (Right to Buy)

*All Values are in $ Million

Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures

Data as reported to USA Exchanges

View All The Insider Trades